{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:10:17Z","timestamp":1790669417828,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.arcmed.2013.10.005","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T15:00:31Z","timestamp":1386255631000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Expressions of MAGE-A9 and MAGE-A11 in Breast Cancer and their Expression Mechanism"],"prefix":"10.1016","volume":"45","author":[{"given":"Shu-yun","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-xiang","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-zhi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-hua","family":"L\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-en","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2013.10.005_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1054\/bjoc.2001.1974","article-title":"Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas","volume":"85","author":"Mashino","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.arcmed.2013.10.005_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jcp.10215","article-title":"Cancer\/testis-associated genes: identification, expression profile, and putative function","volume":"194","author":"Zendman","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.arcmed.2013.10.005_bib3","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/testis (CT) antigens: potential targets for immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.arcmed.2013.10.005_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2012.05.011","article-title":"MAGE-A antigens as targets in tumour therapy","volume":"324","author":"Meek","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2013.10.005_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2013.10.005_bib6","first-page":"5544","article-title":"An overview of the MAGE gene family with the identification of all human members of the family","volume":"61","author":"Chomez","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2013.10.005_bib7","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/MCB.19.11.7327","article-title":"DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter","volume":"19","author":"De Smet","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2013.10.005_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00262-008-0582-6","article-title":"Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules","volume":"58","author":"Adair","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.arcmed.2013.10.005_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/1541-7786.MCR-05-0229","article-title":"Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and-A12 in human cancer cells","volume":"4","author":"Wischnewski","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.arcmed.2013.10.005_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF01246677","article-title":"Structure, chromosomal localization, and expression of 12 genes of the MAGE family","volume":"40","author":"De Plaen","year":"1994","journal-title":"Immunogenetics"},{"key":"10.1016\/j.arcmed.2013.10.005_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910630313","article-title":"Expression of MAGE genes in primary and metastatic cutaneous melanoma","volume":"63","author":"Brasseur","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2013.10.005_bib12","first-page":"6682","article-title":"MAGE-A gene expression pattern in primary breast cancer","volume":"61","author":"Otte","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2013.10.005_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00432-008-0484-1","article-title":"MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors","volume":"135","author":"Grau","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.arcmed.2013.10.005_bib14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/ijc.24503","article-title":"High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer","volume":"125","author":"Bergeron","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2013.10.005_bib15","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-05-3327","article-title":"Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis","volume":"66","author":"Peikert","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2013.10.005_bib16","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.3748\/wjg.v12.i35.5651","article-title":"Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues","volume":"12","author":"Kim","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2013.10.005_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1011308707512","article-title":"Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer","volume":"6","author":"Yan","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.arcmed.2013.10.005_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/stem.160413","article-title":"The HER-2\/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy","volume":"16","author":"Ross","year":"1998","journal-title":"Stem Cells"},{"key":"10.1016\/j.arcmed.2013.10.005_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1634\/theoncologist.8-4-307","article-title":"The Her-2\/neu gene and protein in breast cancer 2003: biomarker and target of therapy","volume":"8","author":"Ross","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.arcmed.2013.10.005_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10637-005-2899-8","article-title":"Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer","volume":"23","author":"Yeon","year":"2005","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.arcmed.2013.10.005_bib21","doi-asserted-by":"crossref","first-page":"8496","DOI":"10.1016\/j.vaccine.2011.09.014","article-title":"MAGE-A family: attractive targets for cancer immunotherapy","volume":"29","author":"Sang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2013.10.005_bib22","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1158\/1078-0432.CCR-06-0669","article-title":"Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura","volume":"12","author":"Schrump","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2013.10.005_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0003-4975(00)02421-8","article-title":"Induction of MAGE-3 expression in lung and esophageal cancer cells","volume":"71","author":"Weiser","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.arcmed.2013.10.005_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/30613","article-title":"Gene silencing. Methylation meets acetylation","volume":"393","author":"Bestor","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2013.10.005_bib25","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1038\/sj.onc.1205357","article-title":"MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland","volume":"21","author":"Billard","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2013.10.005_bib26","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/ijc.22282","article-title":"MAGE-A9 mRNA and protein expression in bladder cancer","volume":"120","author":"Picard","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2013.10.005_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/mc.10145","article-title":"Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells","volume":"38","author":"Donadelli","year":"2003","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.arcmed.2013.10.005_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2010.10.021","article-title":"Melanoma-associated antigen genes\u2014an update","volume":"302","author":"Sang","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2013.10.005_bib29","first-page":"895s","article-title":"Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12","volume":"7","author":"Gajewski","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2013.10.005_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0959-8049(02)00479-3","article-title":"Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report","volume":"39","author":"Marchand","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.arcmed.2013.10.005_bib31","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.4049\/jimmunol.171.9.4898","article-title":"Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus","volume":"171","author":"Karanikas","year":"2003","journal-title":"J Immunol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440913002282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440913002282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:42:29Z","timestamp":1759261349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440913002282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0188440913002282"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2013.10.005","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expressions of MAGE-A9 and MAGE-A11 in Breast Cancer and their Expression Mechanism","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2013.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}